Table 1 Patient baseline characteristics
Characteristics | Number of patients |
|---|---|
Eligible patients | 41 |
Age (years) | |
Median | 42 |
Range | 17–68 |
Sex | |
M:F | 29:12 |
WHO performance status | |
0 | 13 |
1 | 23 |
2 | 5 |
B symptoms | |
Yes | 13 |
No | 28 |
Stage | |
1–2 | 11 |
3–4 | 30 |
LDH | |
⩽ULN | 15 |
>ULN | 26 |
Extra-nodal sites | |
<2 | 35 |
⩾2 | 6 |
Histology | |
Hodgkin's lymphoma | |
Nodular sclerosing | 16 |
Lymphocyte predominant | 1 |
B-cell type | |
Follicular Lymphoma Grade 1–3A | 3 |
Diffuse large B-cell lymphoma | 10 |
T-cell-rich B-cell lymphoma | 2 |
Mantle cell lymphoma | 1 |
T-cell type | |
T/NK cell | 1 |
Angioimmunoblastic lymphoma | 1 |
Anaplastic large cell lymphoma | 3 |
Enteropathy associated lymphoma | 1 |
